Search

Your search keyword '"Gatell J. M."' showing total 579 results

Search Constraints

Start Over You searched for: Author "Gatell J. M." Remove constraint Author: "Gatell J. M."
579 results on '"Gatell J. M."'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

6. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

7. Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group

8. HIV in the Intensive Care Unit

9. Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

15. Epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in Barcelona, Spain (1997–2015): a prospective cohort study

16. Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status

19. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response:a sub-study of the NEAT001/ANRS143 randomized trial

25. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

26. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions

28. Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort

35. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

37. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

39. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

47. Intrathoracic fat in HIV-infected patients

Catalog

Books, media, physical & digital resources